stockchase picture

Compiling comments that experts make about stocks while on public TV.

2012-07-09

Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned
COMMENT $65.610 CAUTIOUS NORTH AMERICAN - LARGE Yes

Will be splitting the company into 2 parts, pharma side and medical devices. Purchased a generic company out of India last year and India will be providing health care to the general population but will only pay for generic drugs . Currently within a couple of dollars of her target price so she might shave some of her holdings.

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management

No Comments.


You must be logged in to comment.